Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Net Margin (2016 - 2025)

Historic Net Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 26.81%.

  • Utah Medical Products' Net Margin fell 88000.0% to 26.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.08%, marking a year-over-year decrease of 45300.0%. This contributed to the annual value of 33.09% for FY2024, which is 12000.0% up from last year.
  • Latest data reveals that Utah Medical Products reported Net Margin of 26.81% as of Q3 2025, which was down 88000.0% from 30.62% recorded in Q2 2025.
  • Utah Medical Products' 5-year Net Margin high stood at 35.61% for Q3 2024, and its period low was 26.81% during Q3 2025.
  • Its 5-year average for Net Margin is 31.55%, with a median of 31.69% in 2024.
  • Per our database at Business Quant, Utah Medical Products' Net Margin soared by 122400bps in 2021 and then crashed by -88000bps in 2025.
  • Over the past 5 years, Utah Medical Products' Net Margin (Quarter) stood at 32.0% in 2021, then fell by -5bps to 30.27% in 2022, then increased by 15bps to 34.75% in 2023, then fell by -9bps to 31.69% in 2024, then decreased by -15bps to 26.81% in 2025.
  • Its Net Margin was 26.81% in Q3 2025, compared to 30.62% in Q2 2025 and 31.32% in Q1 2025.